Recondria Therapeutics

Recondria Therapeutics is a developer of a mitochondrial transplantation platform designed to restore cellular energy, accelerate tissue recovery and support regenerative medicine.

The company's approach involves isolating healthy mitochondria and delivering them to damaged cells to restore ATP production and cellular function.

Recondria is exploring applications of its platform across neurology, cardiovascular health, rare genetic disorders, metabolic disorders and healthy ageing, aiming to support long-term tissue repair and cellular vitality.